Drug Trial Radar · NCT02931539
Efficacy and Safety Study of Maribavir Treatment Compared to Investigator-assigned Treatment in Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory or Resistant to Treatment With Ganciclovir, Valganciclovir, Foscarnet, or Cidofovir
Last checked: Nov 19, 2026Latest source record: Nov 3, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
352
Actual
Start
Dec 22, 2016
Primary completion
Aug 17, 2020
Study completion Aug 17, 2020
Sponsor
- Lead sponsor
- ShireTakeda (TAK)
- Sponsor type
- Industry
- First posted
- Oct 13, 2016
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 12 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to compare the efficacy of maribavir to investigator-assigned anti-Cytomegalovirus (CMV) therapy in CMV viremia clearance in transplant recipients who are refractory or resistant to prior anti-CMV treatment.
Conditions
- Cytomegalovirus (CMV)
Interventions
MaribavirDrug
Maribavir 400 milligrams (mg) (2x200 mg tablets) will be administered twice daily for 8 weeks.
GanciclovirDrug
Ganciclovir as per the investigator's prescribed dosing regimen will be administered for 8 weeks.
ValganciclovirDrug
Valganciclovir as per the investigator's prescribed dosing regimen will be administered for 8 weeks.
FoscarnetDrug
Foscarnet as per the investigator's prescribed dosing regimen will be administered for 8 weeks.
CidofovirDrug
Cidofovir as per the investigator's prescribed dosing regimen will be administered for 8 weeks.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants Who Achieved Confirmed Clearance of Plasma Cytomegalovirus (CMV) Deoxyribonucleic Acid (DNA) (CMV Viremia Clearance) at End of Week 8Time frame: Week 8
Locations
134 sites in 14 countries. Site status is shown where the registry gives one.
University of Alabama at Birmingham
Birmingham, Alabama
University of Arizona
Tucson, Arizona
City of Hope National Medical Center
Duarte, California
University of Southern California
Los Angeles, California
UCLA Medical Center
Los Angeles, California
UC Davis Medical Center
Sacramento, California
Stanford University
Stanford, California
Yale University School of Medicine
New Haven, Connecticut
AdventHealth
Orlando, Florida
Emory University Hospital
Atlanta, Georgia
Feinberg School of Medicine Northwestern University
Chicago, Illinois
Loyola University Medical Center
Maywood, Illinois
University of Chicago Medical Center
Maywood, Illinois
University of Kentucky
Lexington, Kentucky
Ochsner Clinic Foundation
New Orleans, Louisiana
University of Maryland
Baltimore, Maryland
Johns Hopkins Hospital
Baltimore, Maryland
Massachusetts General Hospital
Boston, Massachusetts
Brigham and Womens Hospital
Boston, Massachusetts
UMass Memorial Medical Center
Worcester, Massachusetts
University of Michigan
Ann Arbor, Michigan
Henry Ford Health System
Detroit, Michigan
William Beaumont Hospital
Royal Oak, Michigan
University of Minnesota
Minneapolis, Minnesota
Mayo Clinic - PPDS
Rochester, Minnesota
University of Nebraska Medical Center
Omaha, Nebraska
Hackensack University Medical Center
Hackensack, New Jersey
Columbia University Medical Center
New York, New York
Memorial Sloan Kettering Cancer Center
New York, New York
New York Presbyterian Hospital - Weill-Cornell
New York, New York
SUNY Upstate Medical Center
Syracuse, New York
Duke University Medical Center
Durham, North Carolina
The Christ Hospital
Cincinnati, Ohio
University of Cincinnati
Cincinnati, Ohio
Cincinnati Children's Hospital Medical Center - PIN
Cincinnati, Ohio
University Hospitals Cleveland Medical Center
Cleveland, Ohio
Nationwide Children's Hospital
Columbus, Ohio
University of Pennsylvania
Philadelphia, Pennsylvania
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania
Medical University of South Carolina - PPDS
Charleston, South Carolina
Showing 40 of 134 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.